| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4072355 | Journal of Orthopaedic Science | 2009 | 8 Pages |
Abstract
We analyzed the results of the intensive neoadjuvant chemotherapy and the effects of adding IFO on patients with osteosarcoma in Japan. The results suggest efficacy of the high-dose IFO addition to the standard three-drug chemotherapy regimen. However, a randomized clinical study is needed to establish the true impact of IFO on patients with osteosarcoma.
Related Topics
Health Sciences
Medicine and Dentistry
Orthopedics, Sports Medicine and Rehabilitation
Authors
Yukihide Iwamoto, Kazuhiro Tanaka, Kazuo Isu, Akira Kawai, Shin-ichiro Tatezaki, Takeshi Ishii, Kazuyoshi Kushida, Yasuo Beppu, Masamichi Usui, Akio Tateishi, Kiyoo Furuse, Takeshi Minamizaki, Noriyoshi Kawaguchi, Shinya Yamawaki,